These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 8965315)
1. [Breast carcinoma: evaluation of hormone receptors and pS2, erb-B2, P-glycoprotein and Ki-67 markers]. Abadjian G; Antoun R J Med Liban; 1996; 44(1):10-5. PubMed ID: 8965315 [TBL] [Abstract][Full Text] [Related]
2. [Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma]. Göhring UJ; Scharl A; Ahr A Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):177-83. PubMed ID: 8682282 [TBL] [Abstract][Full Text] [Related]
3. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast]. Sánchez Salmón A; Argibay S; Arias JI; Ruibal A Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785 [TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay]. Ahr A; Scharl A; Göhring UJ; Crombach G; Stoffl M Pathologe; 1995 Jul; 16(4):278-84. PubMed ID: 7667210 [TBL] [Abstract][Full Text] [Related]
5. Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer. Relationship between differentiation degree and axillary lymph node metastases. Sirvent JJ; Santafé M; Salvadó MT; Alvaro T; Raventós A; Palacios J Histol Histopathol; 1994 Jul; 9(3):563-70. PubMed ID: 7526910 [TBL] [Abstract][Full Text] [Related]
6. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer]. Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer. Kondov B; Kondov G; Spirovski Z; Milenkovikj Z; Colanceski R; Petrusevska G; Pesevska M Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Mar; 38(1):81-90. PubMed ID: 28593885 [TBL] [Abstract][Full Text] [Related]
8. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Agudo D; Gómez-Esquer F; Martínez-Arribas F; Núñez-Villar MJ; Pollán M; Schneider J Int J Cancer; 2004 May; 109(5):717-20. PubMed ID: 14999780 [TBL] [Abstract][Full Text] [Related]
9. pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Schwartz LH; Koerner FC; Edgerton SM; Sawicka JM; Rio MC; Bellocq JP; Chambon P; Thor AD Cancer Res; 1991 Jan; 51(2):624-8. PubMed ID: 1985778 [TBL] [Abstract][Full Text] [Related]
10. [Biomorphological features of "minimal" carcinomas selected from a series of 2077 breast cancer cases]. Martinazzi M; Mauri FM; Calandra C; Hotz AM; Crivelli F Pathologica; 2000 Apr; 92(2):65-71. PubMed ID: 10838870 [TBL] [Abstract][Full Text] [Related]
11. Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer. Campani D; Sarnelli R; Fontanini G; Martini L; Cecchetti D; De Luca F; Squartini F Ann N Y Acad Sci; 1993 Nov; 698():167-73. PubMed ID: 7904137 [No Abstract] [Full Text] [Related]
12. Comparison of the expression of prognostic biomarkers between primary tumor and axillary lymph node metastases in breast cancer. Zhao S; Xu L; Liu W; Lv C; Zhang K; Gao H; Wang J; Ma R Int J Clin Exp Pathol; 2015; 8(5):5744-8. PubMed ID: 26191291 [TBL] [Abstract][Full Text] [Related]
13. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Buck A; Schirrmeister H; Kühn T; Shen C; Kalker T; Kotzerke J; Dankerl A; Glatting G; Reske S; Mattfeldt T Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1317-23. PubMed ID: 12271413 [TBL] [Abstract][Full Text] [Related]
14. Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas. Hurlimann J; Gebhard S; Gomez F Histopathology; 1993 Sep; 23(3):239-48. PubMed ID: 8225242 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors. Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years. Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR. Charpin C; Bonnier P; Khouzami A; Vacheret H; Andrac L; Lavaut MN; Allasia C; Piana L Anticancer Res; 1992; 12(3):591-7. PubMed ID: 1352440 [TBL] [Abstract][Full Text] [Related]
18. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients. Soubeyran I; Quénel N; Coindre JM; Bonichon F; Durand M; Wafflart J; Mauriac L Br J Cancer; 1996 Oct; 74(7):1120-5. PubMed ID: 8855985 [TBL] [Abstract][Full Text] [Related]
19. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956 [TBL] [Abstract][Full Text] [Related]
20. [PS2 as a prognostic factor in 1065 cases of human breast cancer. A multicenter study]. Besse G; Kwiatkowski F; Gaillard G; Daver A; Dalifard I; Basuyau JP; Brunelle P; Wafflart J; Angibeau RM; Auvray E Bull Cancer; 1994 Apr; 81(4):289-96. PubMed ID: 7703545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]